Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of Autologous Culture Expanded Adipose Derived Mesenchymal Stromal Cells in the Treatment of Painful Knee Osteoarthritis

NCT02805855 is registered in ClinicalTrials.gov with Jacob L. Sellon, M.D. as lead sponsor.

NCT NCT02805855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02805855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of Autologous Culture Expanded Adipose Derived Mesenchymal Stromal Cells in the Treatment of Painful Knee Osteoarthritis
Lead sponsor
Jacob L. Sellon, M.D.
Phase
Phase 1
Overall status
Completed
Start date
October 26, 2016
Completion date
September 28, 2023
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, knee